CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $119,908 | -72.3% | 3,121 | -83.3% | 0.00% | -100.0% |
| Q1 2023 | $432,719 | +7.3% | 18,692 | +21.4% | 0.00% | 0.0% |
| Q4 2022 | $403,244 | +33.5% | 15,391 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $302,000 | +12.3% | 15,391 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $269,000 | +7.2% | 15,391 | 0.0% | 0.00% | – |
| Q1 2022 | $251,000 | -13.7% | 15,391 | -13.8% | 0.00% | – |
| Q4 2021 | $291,000 | +48.5% | 17,849 | +16.0% | 0.00% | – |
| Q3 2021 | $196,000 | -9.7% | 15,391 | 0.0% | 0.00% | – |
| Q2 2021 | $217,000 | -9.2% | 15,391 | 0.0% | 0.00% | – |
| Q1 2021 | $239,000 | – | 15,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |